Skip to main content

Plasma Malignancy clinical trials at UCSF
1 in progress, 1 open to new patients

  • MMRF Molecular Profiling Protocol

    open to eligible people ages 18 years and up

    Here we propose an "integrative sequencing approach" utilizing a 1500 gene exome comparative analysis between multiple myeloma or related plasma cell malignancies and normal cells coupled to capture transcriptome sequencing to provide a nearly comprehensive landscape of the genetic alterations for the purpose of identifying informative and/or actionable mutations in patients with multiple myeloma and plasma cell malignancies. The approach will enable the detection of point mutations, insertions/deletions, gene fusions and rearrangements, amplifications/deletions, and outlier expressed genes among other classes of alterations.

    San Francisco, California and other locations